Programmed cell death protein 1 and tyrosine kinase inhibition plus transcatheter arterial chemoembolization of advanced hepatocellular carcinoma-Reference-Cited by-全球学者库

Programmed cell death protein 1 and tyrosine kinase inhibition plus transcatheter arterial chemoembolization of advanced hepatocellular carcinoma

Published:2022-09-27 Issue: Volume: Page:
ISSN:0007-1323
Container-title:British Journal of Surgery
language:en
Short-container-title:

Author:

Peng Wei¹²,Zhang Xiaoyun¹,Li Chuan¹^ORCID,Zhu Xinrui¹,Li Qiu³,Chen Weixia⁴,Lu Wusheng¹,Liu Chang¹,Zhou Yongjie⁵,Shi Yujun⁵,Wen Tianfu¹^ORCID,Sun Xin²

Affiliation:

1. Department of Liver Surgery, West China Hospital, Sichuan University , Chengdu , China

2. Chinese Evidence-based Medicine Centre, West China Hospital, Sichuan University , Chengdu , China

3. Department of Medical Oncology, Cancer Centre, West China Hospital, Sichuan University , Chengdu , China

4. Department of Radiology, West China Hospital, Sichuan University , Chengdu , China

5. Laboratory of Pathology, Key Laboratory of Transplant Engineering and Immunology, NHC, West China Hospital, Sichuan University , Chengdu , China

Abstract

The IDEAL framework allowed safe introduction of salvage liver resection after LEN-TAP strategy in an evidence-based manner without exposing the initial patients to unacceptable risk. The findings showed that LEN-TAP conversion strategy is feasible with manageable AEs for uHCC, and salvage liver resection is safe and beneficial.

Publisher

Oxford University Press (OUP)

Subject

Surgery

Link

https://academic.oup.com/bjs/advance-article-pdf/doi/10.1093/bjs/znac334/46345063/znac334.pdf

Reference19 articles.

1. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE study;Park;Liver Int,2015

2. Salvage surgery following downstaging of unresectable hepatocellular carcinoma;Lau;Ann Surg,2004

3. Alliance of liver cancer conversion therapy CoLCotCA-CA. Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition);Sun;Hepatobiliary Surg Nutr,2022

4. IDEAL Framework for surgical innovation 1: the idea and development stages;McCulloch;BMJ,2013

5. No surgical innovation without evaluation: evolution and further development of the IDEAL framework and recommendations;Hirst;Ann Surg,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of lenvatinib plus transarterial chemoembolization in combination with PD-1 antibody in treatment of unresectable recurrent hepatocellular carcinoma: a case series report;Frontiers in Oncology;2023-05-16